» Articles » PMID: 14645662

Selective Antimicrotubule Activity of N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5) Against Kinetoplastid Parasites

Overview
Journal Mol Pharmacol
Date 2003 Dec 4
PMID 14645662
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Analogs of the antimitotic herbicide oryzalin (3,5-dinitro-N4,N4-di-n-propylsulfanilamide) were recently prepared that were more potent in vitro than the parent compound against the kinetoplastid parasite Leishmania donovani (Bioorg Med Chem Lett 12:2395-2398, 2002). In the present work, we show that the most active molecule in the group, N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5), is a potent, selective antimitotic agent against kinetoplastid parasites. GB-II-5 possesses IC50 values of 0.41 and 0.73 microM in vitro against two strains of the related parasite Trypanosoma brucei but is much less toxic to J774 murine macrophages and PC3 prostate cancer cells, exhibiting IC50 values of 29 and 35 microM against these lines, respectively. Selectivity is also observed for GB-II-5 with purified leishmanial and mammalian tubulin. The assembly of 15 microM leishmanial tubulin is completely inhibited by 10 microM GB-II-5, whereas 40 microM GB-II-5 inhibits the assembly of 15 microM porcine brain tubulin by only 17%. In cultured L. donovani and T. brucei, treatment with 5 and 0.5 microM GB-II-5, respectively, causes a striking increase in the fraction of G2M cells compared with control. Given the potency and selectivity of this agent against kinetoplastid tubulin, GB-II-5 emerges as an exciting new antitrypanosomal and antileishmanial lead compound.

Citing Articles

Unveiling the Possible Oryzalin-Binding Site in the α-Tubulin of .

Aguayo-Ortiz R, Dominguez L ACS Omega. 2022; 7(22):18434-18442.

PMID: 35694483 PMC: 9178734. DOI: 10.1021/acsomega.2c00729.


infection in sheep: Different patterns of virulence and pathogenicity associated with differentially expressed proteomes.

Ramirez-Barrios R, Reyna-Bello A, Parra O, Valeris R, Tavares-Marques L, Brizard J Vet Parasitol X. 2020; 2:100014.

PMID: 32904712 PMC: 7458391. DOI: 10.1016/j.vpoa.2019.100014.


Lead optimization of selective tubulin inhibitors as anti-trypanosomal agents.

Zhao A, Li Y, Orahoske C, Schnur B, Sabbagh A, Zhang W Bioorg Med Chem. 2019; 27(8):1517-1528.

PMID: 30833159 PMC: 6531046. DOI: 10.1016/j.bmc.2019.02.049.


Synthesis, characterization and in vitro antitrypanosomal activities of new carboxamides bearing quinoline moiety.

Ugwu D, Okoro U, Mishra N PLoS One. 2018; 13(1):e0191234.

PMID: 29324817 PMC: 5764481. DOI: 10.1371/journal.pone.0191234.


Synthesis and biological evaluation of selective tubulin inhibitors as anti-trypanosomal agents.

Bobba V, Nanavaty V, Idippily N, Zhao A, Li B, Su B Bioorg Med Chem. 2017; 25(12):3215-3222.

PMID: 28428042 PMC: 5509440. DOI: 10.1016/j.bmc.2017.04.009.